GTI Diagnostics

Devices & Diagnostics

Gen-Probe buys GTI Diagnostics for $53 million

The acquisition allows the San Diego-based company to expand its transplant diagnostics business, according to Gen-Probe. GTI develops medical diagnostic assays for the transplantation, blood bank and specialty coagulation markets. Its human leukocyte antigen, or HLA, antibody detection products are already sold by Gen-Probe under the Lifecodes brand, but the company has also commercialized a number of other HLA-related testing products, including serological typing trays, enzyme immunoassays and molecular typing products for donor-recipient matching, according to Gen-Probe.